Corrigendum to “Obesity III: Obesogen assays: Limitations, strengths, and new directions” [Biochem. Pharmacol. 199 (2022) 115014]
Year: 2022
Type: erratum
Source: Biochemical Pharmacology
Authors: Christopher D. Kassotis, Frederick S. vom Saal, Patrick J. Babin, Dominique Lagadic- Gossmann, Helene Le Mentec, Bruce Blumberg, Nicole Mohajer, Antoine Legrand, Vesna Munic Kos, Corinne Martin-Chouly, Normand Podechard, Sophie Langouët, Charbel Touma, Robert Barouki, Min Ji Kim, Karine Audouze, Mahua Choudhury, Nitya Shree, Amita Bansal, Sarah Howard, Jerrold J. Heindel
Institutions: Wayne State University, University of Missouri, Université de Bordeaux, Inserm, École des Hautes Études en Santé Publique, Institut de Recherche en Santé, Environnement et Travail, Université de Rennes, University of California, Irvine, Karolinska Institutet, Université Paris Cité, Université Sorbonne Paris Nord, Health and Functional Exposomics, Texas A&M University, Australian National University, Commonweal
Language: English
Subfield: Health, Toxicology and Mutagenesis
Field: Environmental Science
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W4282912872